Tweedy Browne Co

#### I. Institutional Overview The 13F filing for **Tweedy Browne Co** for the fourth quarter of 2025 provides a fascinating window into the strategic maneuvers of one of the investment world’s most venerable value-oriented institutions. With a reported portfolio value of approximately **$1.238 billion** and a total of **96 holdings**, Tweedy Browne continues to exemplify a disciplined, research-driven approach that traces its lineage back to the foundational principles of Benjamin Graham. However, the Q4 2025 data reveals a firm that is not merely sitting on its laurels but is actively rebalancing its "conviction bets" to navigate a shifting macroeconomic landscape. Analyzing the **scale and structure** of the portfolio, we see an institution that maintains a moderate size in terms of total assets under management (AUM) disclosed in 13F filings, yet operates with the precision of a much larger entity. The portfolio value of $1.238B suggests a stable capital base, but the internal dynamics of the holdings indicate a period of significant tactical adjustment. With 96 stocks, the institution appears diversified at first glance. However, a deeper look at the concentration levels reveals a "barbell" strategy: a highly concentrated top tier of "conviction holdings" supported by a long tail of smaller, perhaps exploratory or legacy, positions. The **psychological portrait** of Tweedy Browne this quarter is one of **"Calculated Transition."** Value investors are often characterized as contrarian and patient, but the Q4 data shows a proactive stance. The institution is moving away from some of its most successful long-term performers—most notably in the biotechnology and technology sectors—to double down on "Old Economy" industrial and financial assets that likely offer more attractive valuation cushions in an uncertain market. The massive increase in their position in **CNH (CNH Industrial N.V.)** and the strategic trimming of **IONS (Ionis Pharmaceuticals)** suggest a shift from "growth-at-a-reasonable-price" (GARP) or speculative value toward "deep value" and tangible asset plays. Furthermore, the **holding style** reflects a high degree of conviction. The top two holdings alone—Ionis Pharmaceuticals and CNH Industrial—account for over **30% of the total portfolio**. This level of concentration is rare for institutional managers and signals that Tweedy Browne is willing to let its best ideas drive the majority of its performance. It also implies a rigorous bottom-up selection process where only a handful of companies meet the firm’s stringent criteria for "margin of safety" and long-term compounding potential. In summary, Tweedy Browne’s Q4 2025 profile is that of a **disciplined value seeker** that is currently undergoing a portfolio "slimming" and "re-focusing" exercise. By exiting legacy tech positions like Alphabet (Class C) and reducing exposure to high-flying biotech, the firm is recouping capital to fund aggressive expansions in sectors where it perceives a significant disconnect between market price and intrinsic value. This is the hallmark of "smart money": the ability to sell when the thesis has matured and buy when the market is fearful or indifferent toward a specific sector. #### II. Sector Allocation Analysis The sector allocation of Tweedy Browne in Q4 2025 is a masterclass in **thematic concentration**. Unlike many modern hedge funds that chase momentum across a dozen different industries, Tweedy Browne has anchored its capital in three primary pillars: **Financials, Healthcare, and Industrials**. Together, these three sectors represent a staggering **73.62%** of the total portfolio. | Sector | Weight (%) | Trend | | :--- | :--- | :--- | | Financials | 26.36 | Stable/Slight Increase | | Healthcare | 25.33 | Reducing (Profit Taking) | | Industrials | 21.93 | Increasing (Aggressive) | | Consumer Staples | 10.63 | Defensive Anchor | | Consumer Discretionary | 7.66 | Selective Exposure | | Communication Services | 5.38 | Reducing | | Energy | 1.98 | Niche/Tactical | | Technology | 0.49 | Negligible/Avoidance | | Materials | 0.24 | Minimal | **2.1 Concentration and Macro Judgment** The fact that the top three sectors exceed 70% of the portfolio indicates a **highly focused investment philosophy**. Tweedy Browne is clearly not trying to "hug the index." Instead, they are making a macro judgment that the current economic cycle favors companies with strong balance sheets, tangible assets, and essential services. The **Financials (26.36%)** allocation is the largest, suggesting a belief in the resilience of the banking and insurance sectors. This weight is distributed across "money center" banks like **WFC (Wells Fargo)** and **BAC (Bank of America)**, as well as diversified financial services like **BRK.A/B (Berkshire Hathaway)**. In a high-interest-rate or stabilizing-rate environment, these entities often benefit from improved net interest margins and robust capital return programs. Tweedy Browne’s heavy presence here signals a "value-first" approach to the broader economy. **2.2 The Industrial Pivot** The most striking trend this quarter is the rise of **Industrials (21.93%)**. This is driven largely by the aggressive accumulation of **CNH (CNH Industrial)**. Traditionally, industrials are cyclical, but Tweedy Browne’s selection suggests they are looking for "quality cyclicals"—companies that have been unfairly beaten down by short-term economic fears but possess dominant market positions in essential global infrastructure (agriculture, construction, logistics). This move represents an **offensive rotation** into sectors that may benefit from a "re-shoring" of manufacturing or a global infrastructure super-cycle. **2.3 Healthcare: From Growth to Harvest** **Healthcare (25.33%)** remains a cornerstone, but the activity in this sector suggests a "harvesting" phase. The reduction in **IONS (Ionis Pharmaceuticals)**, while still keeping it as the #1 holding, indicates that the institution is locking in gains from a successful multi-year thesis. Healthcare provides a defensive counterbalance to the more cyclical Industrials and Financials. By holding large-cap names like **JNJ (Johnson & Johnson)** and **VRTX (Vertex Pharmaceuticals)**, the firm ensures a steady stream of cash flow and innovation-driven growth that is relatively decoupled from the broader economic cycle. **2.4 The Technology Void** Perhaps the loudest signal in the report is the **Technology (0.49%)** allocation. In an era where the "Magnificent Seven" dominate most institutional portfolios, Tweedy Browne’s near-total avoidance of the tech sector is a bold statement on **valuation discipline**. By exiting **GOOG (Alphabet Class C)** and maintaining only a minimal presence in tech, the firm is essentially saying that the risk-reward profile in the tech sector does not meet their value criteria. They are choosing to avoid the "AI hype" in favor of businesses they can value with greater certainty based on traditional cash flow metrics. **2.5 Macroeconomic Implications** Based on this allocation, we can infer that Tweedy Browne is positioned for a **"Normalization" scenario**. They are avoiding the high-multiple growth stocks that are sensitive to interest rate volatility and instead focusing on sectors that provide "essentiality." Whether it is the food supply chain (Industrials/CNH), the financial plumbing of the economy (Financials), or life-saving medicine (Healthcare), the portfolio is built to withstand a variety of economic outcomes while benefiting from a potential "value catch-up" trade. #### III. Top 10 Holdings Deep Dive The Top 10 holdings of Tweedy Browne represent the **"Ballast Stones"** of the portfolio, accounting for approximately **77.31%** of the total reported value. This extreme concentration means that the performance of these ten companies will almost entirely dictate the fund's quarterly results. **Table 3.1: Top 10 Holdings Detail** | Rank | Ticker | Company | Market Value | Weight (%) | Qtr Change | Weight Change | | :--- | :--- | :--- | :--- | :--- | :--- | :--- | | 1 | IONS | Ionis Pharmaceuticals | $195.00M | 15.74 | -15.04% | -0.74 | | 2 | CNH | CNH Industrial N.V. | $186.07M | 15.02 | +51.95% | +2.50 | | 3 | KOF | Coca-Cola FEMSA | $112.59M | 9.09 | -1.46% | +0.38 | | 4 | BRK.A | Berkshire Hathaway | $108.69M | 8.78 | 0.00% | -0.65 | | 5 | GOOGL | Alphabet Inc. (A) | $62.46M | 5.04 | -14.71% | +0.10 | | 6 | WFC | Wells Fargo & Co. | $52.13M | 4.21 | -3.82% | -0.02 | | 7 | JNJ | Johnson & Johnson | $48.86M | 3.94 | -2.45% | +0.04 | | 8 | BRK ---